his and her health CNBC confirmed on Tuesday that it has donated $1 million to President-elect Donald Trump’s inaugural fund.
The company, which offers a range of direct-to-consumer treatments for conditions including weight loss, erectile dysfunction and hair loss, is the latest in a string of tech companies trying to curry favor with the incoming administration. OpenAI CEO Sam Altman and Yuan Both companies announced late last year donations of $1 million to the inaugural fund, and Amazon and apple Chief executive Tim Cook also reportedly contributed.
“At Hims & Hers, we stand with the leaders and advocates working to improve America’s broken health care system,” the company said in a statement to CNBC.
Axios His and Her donations were first reported.
Hims & Hers became a breakout star in digital health last year, thanks in large part to the success of its popular new weight-loss products.
The company began prescribing compound semaglutide through its platform in May after launching a weight loss program in late 2023. The drug costs about $1,000 per month. Compound semaglutide is a cheaper, custom-made alternative to brand-name drugs and can be produced when brand-name drugs are available shortage.
The future of compound GLP-1 in the United States is not entirely clear, especially as members of Trump’s circle have expressed conflicting opinions about the drugs more broadly. Robert F. Kennedy Jr., Trump’s pick to be secretary of the Department of Health and Human Services, criticized GLP-1. He told CNBC that the “first response” to obesity should be lifestyle changes, but added that “GLP drugs also have a place.”
Dr. Marty Makary, Trump’s appointee to head the Food and Drug Administration, was a senior executive at telemedicine company Sesame, which connects consumers with doctors who can prescribe compound GLP-1 . In recent years, however, Makary’s role on Sesame Street has been largely ceremonial.
Musk, Tesla The CEO, who has been a close confidant of Trump since the election, has publicly expressed support for the drugs.
Musk wrote in the book: “Nothing will improve the health, longevity, and quality of life of Americans more than making GLP inhibitors available to the public at ultra-low cost.” a post on his social media platform X in December.
Late last year, CNBC attended a reporter event in New York City where Hims & Hers said it would work with the incoming administration and share the company’s view on the value of the drugs.
About The Author
